2016 American Transplant Congress
Laparoscopically Assisted Living Donor Hepatectomy Is Safe and Cost Effective.
Transplantation, Lahey Hospital and Medical Center, Burlington, MA.
The surgical technique employed during living donor hepatectomy (LDH) has evolved since the inception of the procedure, but donor safety is always paramount. We review…2016 American Transplant Congress
Center and Surgeons' Experience Improves Outcome in Adult-to-Adult Living Donor Liver Transplantation: Validation of the Report of the A2ALL Consortium.
Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI.
Background: Adult-to-adult living donor liver transplantation cohort study (A2ALL) has reported improved outcomes in centers with greater experience (>20 cases). The aim of this study…2016 American Transplant Congress
When Living Donor Liver Allografts Fail: Exploring the Pitfalls of Retransplantation Using Deceased Donor Organs.
Background: In the US, living donor liver transplantation (LDLT) is associated with increased long-term graft and patient survival compared to deceased donor liver transplantation (DDLT).…2016 American Transplant Congress
Live Donor Liver Transplantation with Older Donors Only Impacts on a Late HCV Recurrence.
Abdominal Organ Transplant, Toronto General Hospital, Toronto, ON, Canada.
Introduction:Impact of donor age on HCV recurrence in live donor liver transplant (LDLT) recipients is controversial. We compared HCV progression in recipients receiving a graft…2016 American Transplant Congress
Hospital Readmissions Following Discharge After Liver Transplantation (LT).
Surgery, University of Minnesota, Minneapolis, MN.
Background:Our objective was to describe incidence and causes readmissions within 30 days of discharge following liver transplantation (LT).Methodology:Medical records of 1027 consecutive patients who underwent…2016 American Transplant Congress
Mothers Are Often Sensitized and Sensitive: Antibody Mediated Rejection in Child to Mother Living Donor Liver Transplantation.
Background: Partial graft is especially more vulnerable to deleterious effects of donor specific HLA antibodies (DSA). Living liver donors and recipients are often family members.…2015 American Transplant Congress
Notch Signaling Mediates Epithelial-to-Mesenchymal Transition in the Development of Marginal Liver Graft Fibrosis
Depatment of Surgery, The University of Hong Kong, Hong Kong, China.
Background and aims:Although graft size and chronic liver diseases have been proposed as risk factors for post-transplantation liver fibrosis, the underlying mechanisms remained unclear. Our…2015 American Transplant Congress
Short-Term QOL After Live Liver Donation: A New York Center for Liver Transplantation (NYCLT) Report
Introduction: LDLT is an option for selective patients, especially in regions with less opportunity for deceased donors. New York State (NYS) has the most LDLT…2015 American Transplant Congress
Outcomes Between ABO-Incompatible Living Donor Liver Transplantation (LDLT) and ABO-Compatible LDLT: A Matched Study
Backgrounds: Reports from several experienced centers suggested that outcomes of an ABO-incompatible (ABOi) living donor liver transplantation (LDLT) after rituximab and reduction of ABO antibodies…2015 American Transplant Congress
The Impact of Metabolic Syndrome and Prevalent Liver Disease on Living Donor Liver Transplantation: A Pressing Need to Expand the Pool
Background and Aims: Organ shortage has been the ongoing obstacle to expand liver transplantation world-wide. Living donor liver transplantation (LDLT) was hoped to improve this…
- « Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- 18
- Next Page »